Obesity and pregnancy complications.
Hugh E Mighty1, And Jenifer O Fahey
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, 22 South Greene Street, N6E13, Baltimore, MD 21201, USA. hmighty@upi.umaryland.edu
Current Diabetes Reports
|August 10, 2007
Summary
Maternal obesity elevates risks for mothers and newborns, including diabetes and hypertension. Healthcare providers must understand these risks and management strategies for better perinatal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Public Health
Background:
- Increasing prevalence of maternal overweight and obesity.
- Association between high body mass index (BMI) and pregnancy complications.
- Need for enhanced provider awareness and management strategies.
Purpose of the Study:
- To highlight the implications of maternal obesity on perinatal outcomes.
- To inform obstetric care providers about risks associated with elevated BMI.
- To review available management options for pregnant individuals with obesity.
Main Methods:
- Literature review on maternal obesity and perinatal outcomes.
- Analysis of current obstetric guidelines and management protocols.
- Synthesis of data on maternal and neonatal complications.
Main Results:
- Maternal obesity is linked to increased rates of gestational diabetes and hypertensive disorders.
- Elevated BMI correlates with adverse labor and birth complications.
- Neonatal outcomes are significantly impacted by maternal weight status.
Conclusions:
- Maternal obesity presents substantial risks to both mother and neonate.
- Obstetric care providers require updated knowledge on managing obesity during pregnancy.
- Proactive management is crucial for mitigating complications and improving perinatal health.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...